Celgene
develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases... Read moreCelgene
develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases... Read more
CEO
Add
News
Sep 06, 2024
Bloomberg Law
Celgene: Celgene Loses Bid to Knock Out Shareholder Suit Over MS Drug
May 17, 2022
Markets Insider
Celgene: Kessler Topaz Meltzer & Check, LLP Announces Pendency of Class Action on Behalf of Purchasers of Celgene Corporation Common Stock
Mar 02, 2022
centralcharts
Press Release: Celgene : Bristol Myers Squibb Announces Early Participation Results, Upsizing and Early Settlement of Tender Offers
Nov 23, 2021
PR-Inside
Press Release: Celgene : BMY, LSPD SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: ...
Oct 23, 2021
Acrofan
Celgene: BRISTOL-MYERS CVR INVESTORS: December 6, 2021 Filing Deadline in Class Action - Contact Lieff Cabraser
Oct 16, 2021
StreetInsider
Press Release: Celgene : APPH, BMY, EAR, HYZN SHAREHOLDERS - ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Class Action lawsuits filed on behalf of Investors, Lead Plaintiff Deadlines Set
Sep 08, 2021
India Infoline
Celgene: Biocon enters into a settlement agreement with Celgene Corp; stock trades flat
Jun 22, 2021
Webindia123
Celgene: Sun Pharma settles patent dispute with US Celgene Corporation
Feb 23, 2021
StreetInsider
Press Release: Celgene : Bristol Myers Squibb and Celgene Issue Notices of Redemption and Partial Redemption of Certain of Their Senior Notes at "Make Whole" Prices
Feb 05, 2021
Boston Citybizlist
Celgene: How Bristol Myers Squibb's Celgene Buyout Continued to Pay Off in Q4
Celgene Competitors
1
2
3
4
5
6
7
8
9
10